Table 3.
Mean (SD) of each group, mean (SD) difference within each group, and mean (95% CI) difference between groups
Outcome | Groups | Difference within groups | Difference between groups | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Week 0 | Week 8 | Week 12 | Week 8 minus week 0 | Week 12 minus week 0 | Week 8 minus week 0 | Week 12 minus week 0 | |||||||||||||
Exp | Con 1 | Con 2 | Exp | Con 1 | Con 2 | Exp | Con 1 | Con 2 | Exp | Con 1 | Con 2 | Exp | Con 1 | Con 2 | Exp minus Con 1 | Exp minus Con 2 | Exp minus Con 1 | Exp minus Con 2 | |
Goal Attainment Scale (T-score) | 23 (0) n = 12 |
23 (0) n = 11 | 23 (0) n = 14 |
40 (14) n = 12 |
31 (9) n = 9 |
38 (9) n = 12 |
40 (13) n = 12 |
36 (13) n = 8 |
36 (9) n = 12 |
17 (14) | 8 (9) | 15 (9) | 17 (13) | 13 (13) | 13 (9) | 9 (− 20 to 2) | 2 (− 9 to 13) | 4 (− 9 to 17) | 4 (− 7 to 16) |
Box and Block Test(blocks/s) | 0.14 (0.21) n = 9 |
0.00 (0.00) n = 6 |
0.05 (0.10) n = 11 |
0.13 (0.18) n = 9 |
0.01 (0.01) n = 5 |
0.07 (0.16) n = 11 |
0.12 (0.19) n = 9 |
0.02 (0.04) n = 5 |
0.07 (0.15) n = 11 |
− 0.01 (0.05) | 0.01 (0.01) | 0.02 (0.07) | − 0.02 (0.06) | 0.02 (0.04) | 0.02 (0.07) | − 0.02 (− 0.06 to 0.03) | − 0.03 (− 0.09 to 0.03) | − 0.04 (− 0.10 to 0.03) | − 0.04 (− 0.10 to 0.02) |
6-min Walk Test(m/s) | 0.18 (0.16) n = 3 |
0.54 (0.05) n = 5 |
0.46 (0.58) n = 3 |
0.28 (0.24) n = 3 |
0.61 (0.17) n = 4 |
0.46 (0.53) n = 3 |
0.27 (0.23) n = 3 |
0.62 (0.29) n = 4 |
0.35 (0.60) n = 3 |
0.10 (0.09) | 0.07 (0.19) | 0.01 (0.09) | 0.09 (0.09) | 0.08 (0.30) | − 0.11 (0.13) | 0.02 (− 0.29 to 0.33) | 0.09 (− 0.12 to 0.29) | 0.01 (− 0.46 to 0.48) | 0.20 (− 0.05 to 0.44) |
Tardieu Scale(0–4) | 2.5 (0.7) n = 12 |
2.2 (0.4) n = 11 |
2.2 (0.6) n = 14 |
2.5 (0.7) n = 11 |
2.3 (0.5) n = 9 |
2.0 (0.5) n = 13 |
2.3 (0.7) n = 12 |
2.2 (0.4) n = 9 |
2.2 (0.8) n = 12 |
− 0.1 (0.3) | − 0.2 (0.8) | 0.1 (0.3) | − 0.2 (0.4) | 0.0 (1.1) | 0.0 (0.0) | 0.1 (− 0.4 to 0.7) | − 0.2(− 0.4 to 0.1) | − 0.2 (− 0.9 to 0.6) | −20090.2 (− 0.4 to 0.1) |
Exp experimental group (botulinum toxin-A plus intensive therapy), Con 1 control group 1 (botulinum toxin-A only), Con 2 control group 2 (intensive therapy only)